The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

In 2026, the biggest drivers of market trends in ophthalmology include rare diseases as well as gene therapies and AI, ...

BillionToOne, a molecular diagnostics company, announced the launch of a noninvasive test for pregnancies with high fetal ...

Certain demographic and socioeconomic factors were associated with no-show rates for dermatology appointments, according to a ...

Nearly one-third of children with autism were diagnosed by a primary care provider, according to a study of Medicaid data ...

Nicole B. Saphier, MD, has replaced Casey Means, MD, as the president’s nominee for surgeon general after months of a stalled ...

Since we have not addressed estate planning in this column for years, we wanted to dedicate another installment on it.

Non-tobacco nicotine use before a positive pregnancy result increased the risk for pregnancy and delivery complications, ...

Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at Congress ...

Having a birth plan in place was associated with improved maternal and neonatal outcomes, according to research presented at ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal ...